Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn M Marshall

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
The Medical Journal of Australia|June 9, 2005
Proteomics and disease: opportunities and challengesMaria Kavallaris, Glenn M Marshall
Neuroscience Letters|August 30, 2005
Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiationLoen M Hansford, Glenn M Marshall
Cancer Research|February 27, 2009
The critical role of the class III histone deacetylase SIRT1 in cancerTao Liu, Pei Y Liu, Glenn M Marshall
Cancer Treatment Reviews|March 7, 2006
Histone deacetylase inhibitors: multifunctional anticancer agentsTao Liu, Selena Kuljaca, Andrew Tee, et al.
The Medical Journal of Australia|January 18, 2005
Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapyDavid S Ziegler, Luciano Dalla Pozza, Keith D Waters, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2013
TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localizationJessica L Bell, Alena Malyukova, Maria Kavallaris, et al.
Translational Pediatrics|February 3, 2016
Down syndrome and leukemia: insights into leukemogenesis and translational targetsMarion K Mateos, Draga Barbaric, Sally-Anne Byatt, et al.
British Journal of Cancer|September 24, 2025
Factors that influence the uptake of precision-guided treatment recommendations in paediatric cancer: a systematic reviewXian Zou, Tarini Srivastava, Kate Hetherington, et al.
Cancer Letters|February 16, 2010
MYCN oncoprotein targets and their therapeutic potentialEmma Bell, Lindi Chen, Tao Liu, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer CellsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
The Medical Journal of Australia|June 9, 2005
Proteomics and disease: opportunities and challengesMaria Kavallaris, Glenn M Marshall
Neuroscience Letters|August 30, 2005
Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiationLoen M Hansford, Glenn M Marshall
Cancer Research|February 27, 2009
The critical role of the class III histone deacetylase SIRT1 in cancerTao Liu, Pei Y Liu, Glenn M Marshall
Cancer Treatment Reviews|March 7, 2006
Histone deacetylase inhibitors: multifunctional anticancer agentsTao Liu, Selena Kuljaca, Andrew Tee, et al.
The Medical Journal of Australia|January 18, 2005
Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapyDavid S Ziegler, Luciano Dalla Pozza, Keith D Waters, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2013
TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localizationJessica L Bell, Alena Malyukova, Maria Kavallaris, et al.
Translational Pediatrics|February 3, 2016
Down syndrome and leukemia: insights into leukemogenesis and translational targetsMarion K Mateos, Draga Barbaric, Sally-Anne Byatt, et al.
British Journal of Cancer|September 24, 2025
Factors that influence the uptake of precision-guided treatment recommendations in paediatric cancer: a systematic reviewXian Zou, Tarini Srivastava, Kate Hetherington, et al.
Cancer Letters|February 16, 2010
MYCN oncoprotein targets and their therapeutic potentialEmma Bell, Lindi Chen, Tao Liu, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer CellsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Pageof 18